AMAnna Marcinkowska

Anna Marcinkowska

*This is an algorithmically generated author record based on publicly available information.

Anna Marcinkowska has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern approaches to the treatment of atopic dermatitis in children: The role of biologics and Janus kinase inhibitors

    by Sabina Maria Jóźwiak, Karolina Pawelec, Jakub Jagiełło, Adam Jakubas, Karolina Iwanicka, Laura Maria Surdacka-Barańska, Mateusz Kaczmarski, Paweł Kamiński, Anna Marcinkowska, Simone Szymczyk

    Atopic dermatitis (AD) is a chronic, inflammatory skin disease that often begins in early childhood and significantly affects the quality of life of patients and their families. Conventional treatments include emollients, corticosteroids, and calcineurin inhibitors; however, these are often insufficient in moderate-to-severe cases. In recent years, novel targeted therapies, including biologics and Janus kinase (JAK) inhibitors, have shown promising clinical results in pediatric patients. Dupilumab and tralokinumab, monoclonal antibodies, have demonstrated significant improvement in AD symptoms, including reduction of pruritus and inflammation. JAK inhibitors, such as upadacitinib, abrocitinib, and baricitinib, modulate cytokine pathways involved in AD pathogenesis, leading to rapid and sustained improvement of skin lesions. These novel therapies exhibit favorable safety profiles and enable personalized approaches. This article reviews current evidence on the efficacy and safety of dupilumab, tralokinumab, and JAK inhibitors in the pediatric population, highlighting their role in modern AD management.

  • Open Access

    Gut - Brain - Ovary Axis in Polycystic Ovary Syndrome: Microbiota, Metabolic Inflammation, and Reproductive Dysfunction

    by Jakub Lech, Anna Marcinkowska, Julia Nowosielska, Karol Stobiński, Aleksandra Płusa, Natalia Pluta, Patryk Barczuk, Urszula Załuska, Weronika Kopyt, Katarzyna Latalska

    IntroductionPolycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by reproductive, metabolic, and inflammatory disturbances. Increasing evidence suggests that gut microbiota plays a significant role in the regulation of metabolic and neuroendocrine pathways involved in PCOS. AimThe aim of this review was to summarize current knowledge on the gut-brain-ovary axis in PCOS, with particular focus on the contribution of gut microbiota dysbiosis to metabolic inflammation and reproductive dysfunction. Material and methodsA narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Peer-reviewed articles published in English up to March 2024 were analyzed. Studies addressing associations, underlying mechanisms, and therapeutic interventions linking gut microbiota with metabolic, inflammatory, neuroendocrine, and reproductive features of PCOS were included. ResultsAvailable evidence indicates that women with PCOS exhibit significant alterations in gut microbiota composition, including reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and increased prevalence of pro-inflammatory taxa. These changes are associated with insulin resistance, impaired intestinal barrier function, metabolic endotoxemia, chronic low-grade inflammation, hyperandrogenism, and disturbances in hypothalamic-pituitary-ovarian signaling. ConclusionsGut microbiota dysbiosis appears to play an important integrative role in the pathophysiology of PCOS by linking metabolic inflammation with neuroendocrine and ovarian dysfunction. The gut-brain-ovary axis represents a promising conceptual framework and therapeutic target; however, further well-designed longitudinal and mechanistic studies are required.

  • Open Access

    Wearable Technologies in Team Sports: A Systematic Review of Their Role in Training Load Management and Injury Prevention

    by Urszula Zaluska, Simone Szymczyk, Patryk Barczuk, Natalia Pluta, Karol Stobiński, Anna Marcinkowska, Jakub Lech, Aleksandra Płusa, Weronika Kopyt, Sabina Jóźwiak

    The rapid development of wearable technologies has significantly influenced contemporary team sports by enabling advanced athlete monitoring and supporting data-driven training management. The aim of this systematic review was to evaluate the role of wearable technologies in team sports, with particular emphasis on training load monitoring, athlete performance analysis, and injury prevention. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, and studies were selected according to predefined inclusion and exclusion criteria. The analyzed literature indicates that wearable technologies, such as global positioning systems (GPS), inertial measurement units (IMU), accelerometers, and heart rate monitors, are widely used to assess both external and internal training load. These systems enable continuous data collection on movement patterns, physiological responses, and biomechanical demands during training and competition. As a result, they support workload evaluation, facilitate individualized training programs, and enhance evidence-based decision-making. Wearable technologies also contribute to injury prevention by enabling monitoring of cumulative load and sudden changes in training intensity, which may indicate increased injury risk. However, limitations remain, including issues related to measurement validity, inter-device variability, and challenges in data interpretation. In conclusion, wearable technologies represent valuable tools for improving athlete monitoring, optimizing training processes, and supporting injury prevention in team sports. Their effectiveness depends on both device accuracy and appropriate data interpretation. Further research is needed to standardize their application across different sports and performance levels.